Obesity: Latest

• Beyond BMI: Weight Loss Produces More Health Benefits   Dr Sarah Barenbaum discusses realistic weight-loss goals.
  Medscape, April 11, 2025
• ATTD 2025 GLP-1s Eyed as Key to Managing T1D With Obesity As obesity rates rise among individuals with T1D, GLP-1 agonist medications, indicated for T2D and weight loss, are increasingly viewed as adjuncts to insulin.
  Medscape Medical News, April 11, 2025
• Weight-Loss Surgery Instead of GLP-1s? In the long term, bariatric surgery is more cost-effective than new anti-obesity medications, research finds, triggering a call to suggest patients consider surgery — or both.
  Medscape Medical News, April 11, 2025
• ACP-IM 2025 Eye-Opening Updates in Insomnia and OSA Expert shares treatment approaches for insomnia and alternatives for patients With PAP-intolerance.
  Medscape Medical News, April 11, 2025
• Sucralose Affects Brain Mechanisms That Regulate Appetite The noncaloric sweetener sucralose appears to influence how the hypothalamus interprets sweet taste and metabolic signals, potentially influencing appetite regulation over time.
  Medscape Medical News, April 10, 2025
• Inflammatory Marker Predicts Liver Cancer Risk in T2D An inflammatory biomarker, YKL-40, serves as a reliable prognostic marker for liver and bladder cancers in patients with newly diagnosed T2D, outperforming CRP for these cancers.
  Medscape News UK, April 10, 2025
• Mediterranean Diet and Exercise Boost Bone Health in Seniors An energy-restricted Mediterranean diet plus physical activity can mitigate weight loss and age-related decline in bone mineral density in older women with metabolic syndrome and overweight or obesity.
  Medscape Medical News, April 10, 2025
• The Era of Compounded GLP-1 Drugs Is Over. What Now? Physicians are turning to other options, including older, cheaper medications, as compounding GLP-1s comes to an end.
  Medscape Medical News, April 10, 2025
• Cancer Deaths Fall in Europe, but Not Across All Types A new study has revealed significant reductions in cancer deaths across Europe, yet critical challenges persist for specific tumour types.
  Medscape News UK, April 10, 2025
• Surgery Tops Lifestyle Changes in Patients With Cirrhosis The cost-effectiveness of the surgery, particularly for those with cirrhosis, is significant compared with those only receiving a lifestyle modification program.
  Medscape Medical News, April 09, 2025
• Fast Five Quiz: Long Term Outcomes of Obesity What you know about the long-term outcomes of obesity? Check your knowledge with this quick quiz.
  Medscape, April 08, 2025
• Fast Five Quiz: Gastrointestinal Disease in Obesity What do you know about gastrointestinal disease in obesity? Check your knowledge with this quick quiz.
  Medscape, April 08, 2025
• Primary Care Practices See Steady Rise in Diabetes Cases As diabetes cases soar in the US, physicians are sounding the alarm, especially in economically challenged regions. The push for intensive screening and proactive management has never been more critical.
  Medscape Medical News, April 07, 2025
• USCAP 2025 Noninvasive Tests Unreliable in Assessing Liver Fibrosis Major discrepancies are seen with the use of noninvasive tests compared with liver biopsy in a posttransplant setting.
  Medscape Medical News, April 07, 2025
• Rhythm Pharma's Drug for Rare Obesity Meets Late-stage Trial Goal Rhythm Pharmaceuticals said on Monday its drug Imcivree notably reduced weight in patients with a rare obesity disorder caused by damage to the brain, meeting the main goal...
  Reuters Health Information, April 07, 2025
• Study Links Obesity to Biologic Failure in Psoriasis A decade-long study finds that obesity is associated with a significantly increased risk for biologic treatment failure in patients with psoriasis.
  Medscape Medical News, April 07, 2025
• What Else Can GLP-1 Drugs Do for Your Patients? How GLP-1 analogs are reshaping diabetes care and obesity treatment and unlocking potential in cardiovascular, inflammatory, and neurological diseases.
  Medscape Medical News, April 07, 2025
• ACC 2025 WARRIOR Underscores Burden of Nonobstructive Angina in Women Because the trial ended up being underpowered, it did not show a benefit of intensive medical treatment, but there was a high rate of hospitalization in this population, which is not well understood.
  Medscape Medical News, April 04, 2025
• Apr 04 2025 This Week in Cardiology   Trials from the 2025 American College of Cardiology scientific sessions, including the WARRIOR, PROTECT TAVI, DAPATAVI, and SOUL are reviewed by John Mandrola, MD
  theheart.org on Medscape, April 04, 2025
• Helping GLP-1 Patients Focus on Fat Loss vs Weight Loss To prevent muscle loss, more physicians are emphasizing the importance of fat loss vs weight loss for patients taking GLP-1 agonists.
  Medscape Medical News, April 04, 2025